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Introduction: Immunoregulation implies the activation of negative pathways leading to the modulation
of specific immune responses. Co-inhibitory receptors (such as PD-1 and TIM-3) represent possible tools
for this purpose. PD-1 and TIM-3 have been demonstrated to be present on immune cells suggesting
general involvement in immunosuppression such as fetomaternal tolerance. The aim of our study was to
investigate the expression pattern of PD-1, TIM-3, and its ligand Gal-9 on different immune cell subsets
in the peripheral blood and at the fetomaternal interface in pregnant mice.
Methods: TIM-3 and PD-1 expression by peripheral and decidual immune cells from pregnant BALB-c
mice in 2 weeks of gestational age were measures by flow cytometry. Placental galectin-9 expression
was determined by immunohistochemically and RT-PCR.
Results: Gal-9 was found to be present in the spongiotrophoblast layer of the haemochorial placenta.
Decidual NK, NKT and g/d T cells showed increased PD-1 expression and reduced cytotoxic potential
when compared to the periphery. TIM-3 expression by NK cells and g/d T cells is similar both in the
periphery and in the decidua, notably, their relative TIM-3 expression is increased locally which is
associated with reduced lytic activity. Decidual NKT cells exhibit a reduced TIM-3 expression with
increased relative receptor expression and a slightly increased cytotoxicity when compared to the
periphery.
Discussion: Our data reveals a particularly complex, tissue and cell type specific immunoregulatory
mechanism by the investigated co-inhibitory receptors at the fetomaternal interface.
© 2015 Elsevier Ltd. All rights reserved.1. Introduction
During pregnancy, immunological recognition of the semi-
allogenic fetus by the maternal immune system leads to a unique
immune response phenomenon. At the very early stage of preg-
nancy, immunotolerance of the fetus has to be synchronized with
decidual inflammatory processes required for successful-9; Gd, gestation day; PD-1,
emorial Institute formulation
T cell immunoglobulion and
Centre, Department of Med-
y).
s, et al., Feto-maternal immun
ttp://dx.doi.org/10.1016/j.placimplantation and placentation of the embryo. Later on, besides
allowing fetal development the maternal immune system should
be able to generate adequate responses to infections or eradicate
nascent tumor cells. Therefore, controlling and regulating contra-
dictory immune effector functions during pregnancy portrays a key
role in maintaining immune homeostasis. Immunoregulation is
mediated by a complex network of cellular and molecular in-
teractions with the predominant role of regulatory Tcells as cellular
components of the immune system and an increased number of
molecules with immunoregulatory capacity.
TIM-3 was first identified as a receptor specifically expressed by
terminally differentiated IFN-g producing CD4þ T helper 1 (Th1)
and on CD8þ T cytotoxic cells [1]. Several studies demonstrated the
expression of TIM-3 on a variety of immune cells including Th1,
Th17, NK cells, NKT cells, CD4þCD25þ T cells (Tregs) and on cells ofe regulation by TIM-3/galectin-9 pathway and PD-1molecule inmice
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rophages [2], and mast cells [3]. Mounting evidence supports the
crucial role of TIM-3 in regulating immune responses [4] but the
in vivo function of this receptor is still poorly understood. Using an
allogeneic mouse model of pregnancy Chabtini et al. examined the
TIM-3 expression on antigen presentingmyeloid cells and indicated
their possible role in the regulation of tolerance at the fetomaternal
interface [5].
Galectin-9 (Gal-9), an endogenous lectin, was originally
described as a potent eosinophil chemoattractant. Gal-9 can in-
fluence the immune system in different ways [6], either by exac-
erbating the inflammatory process [7] or by exhibiting therapeutic
effects in autoimmune disease models, such as autoimmune
arthritis, experimental allergic encephalomyelitis, and type 1 dia-
betesmellitus. Notably, it is generally believed that the engagement
of Gal-9 by its receptor TIM-3 established the Gal-9/TIM-3 pathway
as a novel regulator of Th1 immunity and tolerance induction [8].
TIM-3 is the most extensively studied Gal-9 receptor. A growing
body of evidence proves that the engagement of these two mole-
cules leads to the death of Th1 and Th17 cells thus negatively
regulates IFN-g secretion, furthermore influences the ability to
induce T cell tolerance and triggers a significant signal cascade to
induce apoptosis of Th1 type immune cells in both mice and
humans [9e11]. Therefore, the connection between TIM-3 and Gal-
9 may function as a negative regulator, dampening Th1- and Th17
driven immune responses and inducing peripheral tolerance by
modulating the Th1/Th2 balance [12].
The TIM-3 mediated immunomodulation was first described as
a clearly negative regulatory mechanism inducing immunotol-
erance and T cell apoptosis [13]. However, there are conflicting data
surrounding the TIM-3 mediated regulation of innate immunity. In
addition to suggesting similar immunosuppressive actions of TIM-3
on innate immune cells, as observed in T cells [14,15], TIM-3 was
also found to promote innate immune responses [2,16]. Moreover,
several recently published papers report that in reference to viral
infections, overexpression of TIM-3 on NK cells was associated with
effector dysfunction [17,18].
Programmed cell death-1 (PD-1) is a receptor and a member of
the B7/CD28 family. It is known to downregulate T cell functions.
PD-1 expression was observed on CD4þ Th- and CD8þ T lympho-
cytes, B lymphocytes, Tregs, NK, NKT cells, DCs, and activated
monocytes [19]. PD-1 is not expressed on resting T cells but is
inducible upon activation [20]. Known ligands of PD-1 include PD-
L1 [21,22] and PD-L2 [23]. The binding of PD-1 on T cells with its
ligand PD-L1 leads to decreased cytokine production and nega-
tively regulates T cell proliferation and cell lysis during immune
responses to pathogens or cancer [24]. Many publications revealed
and characterized PD-1 as a classical exhaustion marker of T cells
with poor effector functions [25,26].
Since pregnancy represents a unique model of local immuno-
tolerance, regulatory pathways exerted by these co-inhibitory
molecules could have significant impact on maternal immuno-
suppression. Therefore, the aim of our study was to investigate
the expression pattern of TIM-3, PD-1 and Gal-9 on different im-
mune cell subsets in the peripheral blood and at the fetomaternal
interface.
2. Materials and methods
2.1. Animal model
Young (2 months) BALB-c mice were purchased from the Pecs
Experimental Central Animal Laboratory and maintained on a 12 h
light/dark cycle at 20e22 C, 40e60% humidity, and were fed with
standard feed pellets and tap water. Potential mates were paired upPlease cite this article in press as: M.Meggyes, et al., Feto-maternal immun
at day 14.5 of pregnancy, Placenta (2015), http://dx.doi.org/10.1016/j.placeach evening and the presence of the copulatory plug was exam-
ined next morning. Once a plug is detected it is considered the
gestation day (gd) 0.5. Gravid females were killed on gd 14.5 by
cervical dislocation, the spleen and the uterine horns were asep-
tically removed. Animal housing, care, and application of experi-
mental procedures were in accordance with institutional
guidelines under approved protocols (No. BA02/2000e20/2006,
University of Pecs).
2.2. Isolation of mononuclear cells from the spleen
Spleens were homogenized thoroughly with a syringe plunger,
and single-cell suspensions were prepared using a 70-mmnylon cell
strainer (BD Pharmingen). Subsequently, cells were washed in
phosphate-buffered saline (PBS). Supernatant was aspirated and
the pellet was resuspended in PBS and filtered via 40-mm nylon cell
strainer (BD Pharmingen). Mononuclear cells were isolated on
FicollePaque (GE Healthcare) gradient. Cells were collected and
resuspended in RPMI 1640 (Lonza) supplemented with penicillin
(Lonza), streptomycin (Lonza) and 10% heat inactivated fetal calf
serum (FCS) (Gibco).
2.3. Isolation of mononuclear cells from the decidua
The conceptus with the placentae was removed from the sur-
rounding area of the endometrial tissue. Then the decidua was
separated from the isolated placentae, sliced with scissors and
finally digested with collagenase (SigmaeAldrich) for 30 min at
37 C. Placentas were removed and divided into pieces for RNA
isolation followed by quantitative real-time PCR (qRT-PCR) and
complete implantations were frozen for immunohistochemistry.
The decidua next were homogenized thoroughly with a syringe
plunger, and single-cell suspensions were prepared using a 70-mm
nylon cell strainer. Subsequently, cells were washed in RPMI 1640
supplemented with penicillin, streptomycin and 10% FCS. The su-
pernatant was aspirated and the pellet was resuspended in PBS and
filtered via 40-mm nylon cell strainer. Mononuclear cells were iso-
lated on FicollePaque gradient. Cells were collected and resus-
pended in RPMI 1640.
2.4. Labeling of mononuclear cell and flow cytometric analysis
The isolatedmononuclear cells (1 106 in 100 ml PBS/tube) were
incubated for 30min at room temperature (RT) with fluorochrome-
labeled monoclonal antibodies. Following surface staining, the cells
were washed with PBS, resuspended in 300 ml PBS containing 1%
paraformaldehyde (PFA) and stored at 4 C in the dark until
fluorescence-activated cell sorting (FACS) analysis. Labeled cells
were analyzed with a FACSCalibur flow cytometer (BD Immuno-
cytometry Systems, Erembodegen, Belgium) equipped with the
CellQuest software program (BD Biosciences, San Diego, CA, USA)
and a BD FACSCanto II flow cytometer (BD Immunocytometry
Systems, Erembodegen, Belgium) with the BD FACSDiva V6. soft-
ware for data acquisition and analysis.
2.5. Antibodies
The following monoclonal antibodies were implemented:
Brilliant Violet (BV) 421-conjugated anti-mouse PD-1 (BD
Pharmingen), BV510-conjugated anti-mouse CD3 (BD Pharmingen),
BV510-conjugated anti-mouse g/d (BD Pharmingen), fluorescein
isothiocyanate (FITC)-conjugated anti-mouse CD4 (BD Pharmin-
gen), FITC-conjugated anti-mouse CD8 (BD Pharmingen), FITC-
conjugated anti-mouse CD107a (BD Pharmingen), FITC-
conjugated anti-mouse CD49b (BD Pharmingen), FITC-conjugatede regulation by TIM-3/galectin-9 pathway and PD-1molecule inmice
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anti-mouse g/d (BD-Pharmingen), PE-conjugated anti-mouse TIM-
3 (R and D Systems), PE-conjugated anti-mouse Gal-9 (Biolegend),
PE-conjugated anti-mouse CD49b (BD Pharmingen), PE-conjugated
anti-mouse CD8 (BD Pharmingen), peridinin chlorophyll a protein
(PerCP)-conjugated anti-mouse CD3 (BD Pharmingen), PerCP-
conjugated anti-mouse CD45 (BD Pharmingen), PE-Cy7-
conjugated anti-mouse CD25 (BD Pharmingen), allophycocyanin
(APC)-conjugated anti-human TIM-3 (R and D Systems), APC-
conjugated anti-human FoxP3 (eBioscience) and APC-H7-
conjugated anti-human CD8 (BD Pharmingen). Control antibodies
included isotype-matched FITC-conjugated, PE-conjugated, PerCP-
conjugated and APC-conjugated rat antibodies.
2.6. FoxP3 staining
Following surface labeling intracellular staining of FoxP3 was
performed using the FoxP3 Staining Buffer Set (eBioscience)
accordance with the manufacture's protocol. Briefly, cells were
permeabilized in 1 ml fixation/permeabilization buffer (Concen-
trate/Diluent 1:4) for 1 h at 4 C. Then the samples were washed
twice in buffer and stained with the APC-conjugated anti-mouse
FoxP3monoclonal antibody for 1 h at 4 C. Flow cytometric analysis
was performed on FACSCalibur flow cytometer equipped with the
CellQuest software and a BD FACSCanto II flow cytometer with the
BD FACSDiva V6. software for data acquisition and analysis.
2.7. CD107a functional assay
To determine CD107a surface expression, the cells were incu-
bated for 4 h at 37 C in the presence of FITC-conjugated anti-
mouse CD107a monoclonal antibody in RPMI 1640 medium con-
taining 10% FCS, penicillin, streptomycin, ionomycin (Sigma-
eAldrich) and phorbol myristate acetate (PMA), (SigmaeAldrich).
The cells werewashed and resuspended in PBS then incubatedwith
PE-conjugated anti-mouse g/d, PE-conjugated anti-mouse CD8, PE-
conjugated anti-mouse CD49b and PerCP-conjugated anti-mouse
CD3 mAb for 30 min at room temperature in complete darkness.
The cells were washed in PBS, fixed with 1% PFA and evaluated by
FACS.
2.8. PMA/ion treatment
The isolated peripheral and decidual mononuclear cells were
treated in 96-well plates. The cells were diluted to a final concen-
tration of 2  105 cells/0.2 ml in RPMI 1640 supplemented with L-
glutamine, penicillin and streptomycin and washed for 7 min and
centrifuged at 1200 RPM. The supernatant was aspirated and the
cells were resuspended in RPMI 1640 supplemented with 10% FCS,
P, S, PMA (1 ng/ml), Ion (50 ng/ml) and incubated for 24 h at 37 C.
After incubation the plates were centrifuged at 1200 RPM for 7min.
The cell free supernatants were collected, aliquoted and stored
at 80 C in mechanical freezer for additional cytokine analyses.
2.9. Immunohistochemistry (IHC)
Placental tissue sections were embedded in paraffin and 4 mm
thick sections were prepared after being fixed with 4% neutral
formalin for more than 24 h. After being deparaffinized in xylol,
three times in each for 5 min and rehydrated in degraded alcohol
series (96%, 80%, 70%, 50%) for 5 min each, the mouse paraffin-
embedded tissue sections were washed in distilled water (dH2O).
Afterward the antigen retrieval was performed in boiling citrate
buffer for 20 min (1:10; pH 6.0e6.2; Dako). Next, the samples were
cooled down to RT and a double washing step was performed withPlease cite this article in press as: M.Meggyes, et al., Feto-maternal immun
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were kept for 15 min in 3% H2O2, which was diluted in TBS. The
revealing was finished by a double washing step in dH2O. The
samples were washed twice with TBS supplemented with Tween
(0.05%, pH 7.4) for 5 min and pre-blocked with 3% BSA for 20 min.
The tissue sections were washed with TBST for 5e10 min and
incubated with biotinylated anti mouse Galectin-9 primary anti-
body (1:10; R&D) for 1 h at RT. After washing the slides three times
in TBST the samples were incubated with Streptavidin-Biotinylated
Horseradish Peroxidase Complex (1:100; GE Healthcare) for 30min
at RT. Following the washing procedure (three times), the signal
was detected with Liquid DABþ Substrate Chromogen System
(Dako) for 5e30 min at RT. In an effort to stop and pause the re-
action, the slides were positioned in ultrapure water followed by
two distinct rinse cycles in dH2O was performed. Hematoxylin
counterstainwas performed for 3 min at RT then rinsed three times
with tap water. During the final step, the slides were covered with
gelatin-glycerol solution.
Histological evaluation was performed by a pathologist gener-
ating a qualitative assessment on all tissues sections.
2.10. RNA isolation, cDNS synthesis, qRT-PCR
Placental tissues and resorptions from mice were homogenized
with tissue homogenizer (SigmaeAldrich). Total RNA was isolated
using RNeasyProtect Mini kit (Qiagen) accordance with the man-
ufacturer's protocol. RNA concentration and purity was checked by
spectrophotometry using a Nanodrop ND-1000 (Thermo Fisher
Scientific). Extracted RNA was reverse transcribed into comple-
mentary DNA (cDNA) using the High Capacity RNA-to-cDNA kit
(Applied Biosystems). The differential expression of Gal-9 genewas
confirmed by using qRT-PCR method. The qRT-PCR examinations
were implemented using an SYBR Select Master Mix (Applied
Biosystems) and a Rotor-Gene RG-3000 thermal cycler system
(Corbett Research). QuantiTect primer assays were purchased from
Qiagen for the genes LGALS9 as target and GAPDH as a house-
keeping gene. Specificity of the PCR reaction was controlled by
melting point analysis and gelelectrophoresis of the amplified DNA.
The relative changes (n-fold) in the transcription of the exam-
ined genes between samples were calculated by Rotor-Gene based
on the 2DDCT method. Statistical analysis was performed with
the Relative Expression Software Tool (REST) 2009 [27].
2.11. Statistical analysis
Statistical analysis was performed using the reliable and
preferred statistical software SPSS version 20. Package and the
statistical comparisons were made by using the Student's t-tests.
Distinctly, notable differences were determined significant if the p
value was equal to or less than 0.05.
3. Results
3.1. Immunohistochemistry of pregnant mouse placentae.
We investigated the Gal-9 protein expression at the murine
fetomaternal interface on gd 14.5 using immunohistochemistry. As
a result, our stainings highlight that we can now effectly detect the
Gal-9 molecule in the placentae spongiotrophoblast layer (Fig. 1).
3.2. Gal-9 expression by Treg cells and the proportion of Gal-9þ Th
cell population in spleen and decidua.
We analyzed the surface Gal-9 expression by splenic and
decidual regulatory T cells, in pregnant mice. We discovered ae regulation by TIM-3/galectin-9 pathway and PD-1molecule inmice
enta.2015.07.124
Fig. 2. Gal-9 expression by peripheral and decidual Treg cells and the proportion of G
regulatory T cells T in spleen and decidua in pregnant mice. The histograms represent the d
cells in pregnant mice spleen and decidua. The solid bars represent medians, the boxes
Differences were considered statistically significant for P-values 0.05.
Fig. 1. Immunohistochemical staining of pregnant mouse placentae. IHC was per-
formed on pregnant mouse placentae with anti-Gal-9 antibody and demonstrating the
presence and localization of Gal-9 within the spongiotrophoblast layer and in giant
cells. Obtaining quantitative data from histological sections represent a more intense
staining by trophoblast giant cells compared to spongiotrophoblast layer. The images
were captures utilizing the Pannoramic DESK scanner (3DHISTECH Ltd., Hungary). In
acquiring the analysis, the Pannoramic viewer software was implemented (3DHISTECH
Ltd., Hungary).
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at day 14.5 of pregnancy, Placenta (2015), http://dx.doi.org/10.1016/j.placsignificantly increase in Gal-9 expression by the decidual Treg cells
when compared to the splenic Treg cells (Fig. 2/A).
We could not determine statistical differences in the frequency
of Gal-9 positive Th cells in decidua and spleen (Fig. 2/B).
3.3. Phenotype analysis of splenic and decidual mononuclear cells
from pregnant mice in 2 weeks of gestational age.
In our study, we investigated the percentage of CD4þ, CD8þ T
cells subpopulations, g/d T cells, Treg cells, NK and NKT cells in the
spleen and in the decidua of pregnant mice. We observed a sig-
nificant increase in decidual g/d T, NK and NKT cells frequency
compared to the periphery while the decidual CD4þ, CD8þ T and
Treg cells frequency significantly decreased when compared to the
periphery (Fig. 3).
3.4. Differential TIM-3 and PD-1 expression by splenic and decidual
mononuclear cell subsets.
We measured the surface expression of TIM-3 on different
lymphocyte subsets by flow cytometry. We observed a significantly
decreased TIM-3 expression by decidual NKT cells compared to the
periphery. TIM-3 expression showed no statistical difference be-
tween the spleen and the decidua by NK and g/d T cells (Fig. 4/A).
Furthermore, we also noted a significant increase in receptor
density within the decidual NK, NKT and g/d Tcells when compared
with the periphery (Fig. 4/B).
During our investigation of the PD-1 expression by NK cells, g/
d T and NKT cells in pregnant mice we discovered that all analyzed
cell populations demonstrated an increase in PD-1 expression
within the decidua compared to the periphery (Fig. 4/C).
As a result of our investigation of the peripheral and decidual
TIM-3/PD1 double positive cells we found a significant decrease in
decidual NKT and g/d T cells proportion compared with the pe-
riphery. Lastly, we could not detect TIM-3/PD-1 double positive NK
cells in the examined tissues (Fig. 4/D).
3.5. Cytotoxic activity of different immune cell subsets in the spleen
and in the decidua of pregnant mice.
The cytotoxic activity was evaluated by measuring the CD107a
expression by the investigated cell subsets. We analyzed the
CD107a expression by TIM-3þ cell subsets and our results
demonstrated a significantly decreased CD107a expression by the
decidual TIM-3þ NK and TIM-3þ g/d T cells compared to theal-9þ Th cell population in spleen and decidua. A: The expression of Galectin-9 by
ensity of Gal-9 in splenic and decidual Treg cells. B: The frequency of Gal-9 positive Th
indicate the interquartile ranges and the lines show the most extreme observations.
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Fig. 3. Phenotype analysis of splenic and decidual mononuclear cells. Distribution of splenic and decidual mononuclear cell subsets in pregnant mice. The pie charts slices
represent each subpopulations rate of 8 determinations, respectively. Differences were considered statistically significant for P-values 0.05.
M. Meggyes et al. / Placenta xxx (2015) 1e8 5periphery (Fig 5/A). We observed an increasing tendency in the
CD107a expression by decidual TIM-3 positive NKT cell which did
not attain the level of statistical significance (Fig. 5/A).
Moreover, we analyzed the CD107a expression by the PD-1þ cell
populations. Decidual PD-1 positive NK and NKT cells showed
significantly decreased cytotoxicity compared to the periphery
(Fig. 5/B). Additionally, we discovered a decreased tendency in the
cytotoxic activity by decidual PD-1 positive g/d T cell which did not
reach the level of statistical significance (Fig. 5/B).Fig. 4. TIM-3 and PD-1 molecule expression by splenic and decidual mononuclear cell s
decidua in pregnant mice. B: The density of TIM-3 receptor in splenic and decidual NK cells
cells and g/d T cells in spleen and decidua in pregnant mice. D: The frequency of TIM-3/PD-1
The solid bars represent medians, the boxes indicate the interquartile ranges and the lines sh
for P-values 0.05.
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Gal-9 mRNA with Quantitative Real Time PCR
To determine the relative expression of LGALS9 in placental
tissue and resorbed embryos qRT-PCR analysis was performed with
normalization to GAPDH as a housekeeping gene. We tested four
resorbed embryos in three different mice, and all resorbed embryos
showed a LGALS9 relative expression level of 0.04 compared to
normal placental tissue of the same mouse.ubsets. A: The expression of TIM-3 by NK cells, NKT cells and g/d T cells in spleen and
, NKT cells and g/d T cells in pregnant mice. C: The expression of PD-1 by NK cells, NKT
double positive NK cells, NKT cells and g/d T cells in pregnant mice spleen and decidua.
ow the most extreme observations. Differences were considered statistically significant
e regulation by TIM-3/galectin-9 pathway and PD-1molecule inmice
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Fig. 5. Cytotoxicity of TIM-3 positive and PD-1 positive immune cell subsets in the spleen and in the decidua of pregnant mice. A: The expression of CD107a by TIM-3 positive
NK cells, NKT cells and g/d T cells in pregnant mice spleen and decidua. B: The expression of CD107a by PD-1 positive NK cells, NKT cells and g/d T cells in pregnant mice spleen and
decidua. The solid bars represent medians, the boxes indicate the interquartile ranges and the lines show the most extreme observations. Differences were considered statistically
significant for P-values 0.05.
M. Meggyes et al. / Placenta xxx (2015) 1e864. Discussion
Immunoregulation typically manifests itself in the activation of
negative pathways leading to the exhaustion of specific immune
responses and cellular interactions. Co-inhibitory cell surface re-
ceptors (such as PD-1 and TIM-3) represent one of the primary tools
for this purpose. PD-1 and TIM-3 have demonstrated their presence
on a variety of immune cells emphasizing general involvement of
these molecules in immunosuppression such as fetomaternal
tolerance. Notably, the expression of their ligands is not restricted
to a certain cell lineage but has been described in different tissues
underlines their importance in regulating local immune responses
in vivo.
Decidual expression of the ligands of PD-1 (PDL1 and PDL2) has
been earlier described [28] but we report for the first time on Gal-9
expression in mouse placenta. Gal-9 was found to be present in the
spongiotrophoblast layer of the haemochorial placenta, which
separates the labyrinth layer from the decidua (Fig. 6). Labyrinth
cells have been shown to be MHC class I and II negative, however,
spongiotrophoblast expresses polymorphic paternally derived
MHC class I molecules representing the fetal compartment of
mouse placenta which is in direct contact with maternal deciduaFig. 6. Feto-maternal crosstalk via co-inhibitory molecules and their ligands. The
figure represents one possible pathway of decidual NK, g/d T and NKT cells involved in
local immunomodulation in late mouse pregnancy. TIM-3 and PD-1 molecules are
expressed by decidual NK, NKT and g/d T cells, while PDL1/PDL2 is expressed by the
decidua and Galectin-9 is expressed by Tregs and by the trophoblast.
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possibility of the local presence of Gal-9 is its occurrence on the
maternal side. Gal-9 cell surface expression is one of the immu-
nosuppressive tools of regulatory T cells [32]. Within the scope of
our research, we discovered significantly enhanced Gal-9 expres-
sion by decidual regulatory T cells compared to the periphery.
Moreover, there is a secreted form of Gal-9 produced by Gal-9
positive Th cells [33]. Although there is a decrease in the ratio of
CD4 helper T cells in the decidua, the Gal-9 secreting subpopulation
is still represented locally without any changes. According to our
hypothesis, these dominant presence of the ligands PDL1, PDL2 and
Gal-9 at the fetomaternal interface suggest subsequent local
immunomodulatory potential following maternal
immunoactivation.
Among the lymphocyte subpopulations recruited in the mouse
decidua we found predominantly innate immune cells (NK cells, g/
d T cells and NKT cells) and a reduced number of CD4þ and CD8þ T
lymphocytes compared to the periphery. These data are consistent
with previous studies on decidual lymphocyte enrichment in the
mouse [34e36]. Therefore, we focused on the characteristics of co-
inhibitory receptor expressing NK cells, g/d T cells and NKT cells
(Fig. 6).
During the analysis of the PD-1 expression by lymphocytes in
the periphery and in the decidua, decidual lymphocytes show a
notable increased PD-1 expression in all investigated sub-
populations. Cytotoxicity of the lymphocytes was measured by
analyzing the expression of the degranulation marker CD107a on
the cell surface. Lytic activity of PD-1 positive NK, NKT and g/d T
cells was decreased in the decidua, suggesting the involvement of
these lymphocytes in fetomaternal tolerance as a potential result of
the PD-1 receptor mediated pathway.
While TIM-3 expression of NK cells and g/d Tcells is similar both
in the periphery and in the decidua, the relative TIM-3 expression is
increased locally (higher receptor density on single cell level)
indicating decidual TIM-3 expressing cells are more mature and
fully functional [15]. However, cytotoxic capacity of decidual TIM-3
expressing NK cells and g/d Tcells is reducedwhen compared to the
periphery which might be due to their upregulated relative TIM-3
expression on one hand and a much stronger local presence of its
ligand Gal-9 on the other hand. Their binding could lead to the
subsequent inhibition of effector functions observed here as a
reduced cytotoxicity.
Investigating decidual NKT cells, this subpopulation showed ae regulation by TIM-3/galectin-9 pathway and PD-1molecule inmice
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expression when compared to the periphery. Cytotoxicity of these
cell population increased locally, although not significantly. Ac-
cording to these data, there is a smaller TIM-3þ NKT cell subset in
the decidua with stronger lytic capacity. Subsequently, on decidual
NKT cells TIM-3 appears to promote cellular cytotoxicity than to
suppress NKT cell activity hereby contributing to the mild inflam-
mation required for successful pregnancy.
In analyzing the co-expression of PD-1 and TIM-3 by lympho-
cytes we found a very small percentage of cells involved simulta-
neously in both inhibitory pathways. Moreover, the percentage of
double positive NKT cells and g/d T cells further decreases in the
decidua. Accordingly, these findings emphasize lymphocytes could
be either PD-1 or TIM-3 committed, indicating separate action of
these two co-inhibitory receptors at a cellular level leading to ad-
ditive inhibitory effects considering whole lymphocytes
populations.
Maternal immune responses triggered by the recognition of
different fetal antigens mainly compose of tolerogenic mecha-
nisms but there is also a small inflammatory component both for
fetal (successful placentation and vascular remodeling) and for
maternal advantages (immune protection against pathogens).
These actions are mostly carried out by innate immune cells
enriched in the decidua. We investigated the potential role of co-
inhibitory molecules PD-1 and TIM-3 in maternal immune re-
sponses, since it has been shown their ligands are present at the
fetomaternal interface (Fig. 6). Our research concludes PD-1 and
TIM-3 expressing decidual lymphocytes were found to be more
dominant than in the periphery. While PD-1 positive lymphocytes
show reduced cytotoxicity, lytic activity of TIM-3 expressing cells
varies with cell type suggesting opposite roles of TIM-3 on
different lymphocyte subsets.
Our results were obtained frommice at gestation day 14.5which
is rather late in mouse pregnancy so even more significant Gal-9/
TIM-3, PDL1-PDL2/PD-1 related changes could be observed earlier
in pregnancy, which needs further investigations.
Comprehensively speaking, our data indicates a very complex,
tissue and cell type specific immunoregulatory mechanism by the
investigated co-inhibitory receptors at the fetomaternal interface
proposing further investigations of their exact role in maternal
immune responses.
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